LENZ Therapeutics Inc (NAS:LENZ)
$ 5.51 -0.070 (-1.25%) Market Cap: 172.76 Mil Enterprise Value: -84.95 Mil PE Ratio: 0 PB Ratio: 0.70 GF Score: 12/100

LENZ Therapeutics Inc at Citi Global Healthcare Conference Transcript

Dec 04, 2025 / 03:30PM GMT
Release Date Price: $27.9 (-0.36%)
Yigal Nochomovitz;Douala Branch;Analyst
Citibank Cameroon SA

()-

Welcome, everyone, to the 3rd day of City's Global Healthcare conference. I'm Yigal Nacheovitz, Biotech analyst, here at CI. So we have a really super interesting company, next, it's Lenss Therapeutics. I have with me the CEO Ai Shimmel Pennik.

Thank you, Ai, so much for joining.

Questions & Answers

Yigal Nochomovitz;Douala Branch;Analyst
Citibank Cameroon SA

()-

Obviously, a tremendous amount of progress, since you, did the reverse merge, did the phase 3 data, successfully, built the commercial infrastructure, got the approval, and now, Of course have launched the product. So tell us where you are. Tell us a little bit about the early launch, how it's going, what you're preparing for one que, just, set the stage.

Evert Schimmelpennink
LENZ Therapeutics Inc - President, Chief Executive Officer, Director

Absolutely, thanks, Miguel. Obviously, thanks for the invite.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot